May 8 (Reuters) - Pfizer Inc has agreed to settle more than 10,000 cases about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people familiar with the deal. (Reporting by Leroy Leo in Bengaluru; Editing by Devika Syamnath)
Market Closed -
Other stock markets
|
After market 18:41:38 | |||
28.2 USD | +1.37% | 28.12 | -0.28% |
05-29 | BioNTech gets $145 mln funding for African vaccine plants | RE |
05-29 | BioNTech wins up to $145 mln in CEPI support for African mRNA vaccine plants | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.05% | 158B | |
+39.82% | 731B | |
+31.34% | 586B | |
-7.31% | 348B | |
+14.23% | 319B | |
+0.86% | 273B | |
+13.47% | 235B | |
-6.63% | 203B | |
+7.49% | 202B | |
+4.51% | 159B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Pfizer agrees to settle more than 10,000 Zantac cancer lawsuits - Bloomberg News